MARKET

AMBS

AMBS

Amarantus Biosci
EXMKT
0.0001
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0005
52 WEEK LOW
0.0001
MARKET CAP
63.06K
P/E (TTM)
0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMBS last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at AMBS last week (0126-0130)?
Weekly Report · 02/02 09:56
Weekly Report: what happened at AMBS last week (0119-0123)?
Weekly Report · 01/26 09:56
Weekly Report: what happened at AMBS last week (0112-0116)?
Weekly Report · 01/19 10:00
Weekly Report: what happened at AMBS last week (0105-0109)?
Weekly Report · 01/12 09:59
Weekly Report: what happened at AMBS last week (1229-0102)?
Weekly Report · 01/05 09:55
Weekly Report: what happened at AMBS last week (1222-1226)?
Weekly Report · 12/29/2025 09:55
Weekly Report: what happened at AMBS last week (1215-1219)?
Weekly Report · 12/22/2025 09:55
More
About AMBS
Amarantus Bioscience Holdings, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology and regenerative medicine. The Company owns or has licenses to various product candidates in the biopharmaceutical healthcare industry. It has acquired the rights to the engineered skin substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by Company’s wholly owned subsidiary Cutanogen Corporation. The Company’s wholly owned subsidiary MANF Therapeutics, Inc. owns intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor (MANF). MANF Therapeutics, Inc. is developing MANF-based products as treatments for ophthalmological disorders.

Webull offers Amarantus Bioscience Holdings Inc stock information, including EXMKT: AMBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMBS stock methods without spending real money on the virtual paper trading platform.